MultiCorp International Inc (MCIC)

[G. Falcone]

Keep this PR in mind from October 4th

SUN VALLEY, CA--(Marketwire - October 4, 2010) - XTend Medical Corporation (PINKSHEETS: XMDC), a company that specializes in delivering life-changing medical technology to healthcare organizations globally, has successfully acquired the BioHarp Assets from Mr. Sang M. Lee and U&I Bio-Tech, Inc., as provided in the Asset Purchase Agreement that the parties signed on December 9, 2009. XTend's representatives and Mr. Lee completed the acquisition last Thursday, September 30, 2010, through a mediation proceeding in the Delaware Chancery Court.

Then, from a PR on March 10th 2010 which generally defines what is in the the APA created in December of 2009.

On December 8th, 2009, XTend Medical signed an Asset Purchase Agreement with U & I Bio-Tech, Korea, U & I Bio-Tech, California, and Mr. Sam Lee to acquire the entire BioHarp assets to include all patents, software, hardware, intellectual property, marketing materials, and, in effect, everything that has to do with the BioHarp medical device.

For starters, I don't understand how the APA was signed on December 8th in a PR from March of 2010 in one PR, but from the "successful mediation" PR on October 4th, it was apparently signed on December 9th?

And how did we "successfully acquire" the bioharp assets as provided in the APA that the parties signed on the 9th. (Or was it the 8th?) If we acquired the assets as stated in the APA, then 1. how was this successful if we only received patents? and 2. Having only patents, how could we be so misled with this

XTend has finally secured the BioHarp assets, including the BioHarp patents and other intellectual property. XTend now can move forward with its plans to manufacture and commercialize the BioHarp technology The company is eager to make sales in Korea, Japan, China, and the U.S. as quickly as possible. Additionally, XTend will work to complete audited financials expeditiously in order to become a fully reporting company. The company anticipates being listed on a higher exchange within the first quarter of 2011.

I guess the excuse is that they were sure a manufacturer could whip this thing up from patents.

Now that the company has secured these patents, it can now move quickly to begin the commercialization of the BioHarp Medical device. The company has been in contact with several manufacturers interested in working closely with XTend to produce the BioHarp device.

Funny...We still have not gotten a word about this. Yeah..Guess it's everybody's opinion that it's because the big guys told them to stay quiet...Which makes no sense because they shouldn't have said anything 2 months ago then.

Who is going to deny that we have been clearly misled.